Valuation: Cegedim

Market Cap 15Cr 17Cr 14Cr 12Cr 23Cr 1.6TCr 24Cr 159.17Cr 62Cr 801.14Cr 63Cr 62Cr 2.65TCr P/E 2026 *
6.94x
P/E 2027 * 5.29x
Enterprise Value 31Cr 36Cr 29Cr 26Cr 50Cr 3.38TCr 50Cr 336.82Cr 132.2Cr 1.7TCr 133.46Cr 130.54Cr 5.6TCr EV / Sales 2026 *
0.47x
EV / Sales 2027 * 0.41x
Free-Float
36.52%
Yield 2026 *
-
Yield 2027 * -
1 week+2.13%
Current month+2.13%
1 month+0.86%
3 months-2.86%
6 months-16.68%
Current year-22.50%
1 week 10.1
Extreme 10.1
10.58
1 month 9.99
Extreme 9.99
10.6
3 years 8.66
Extreme 8.66
21.2
5 years 8.66
Extreme 8.66
29.3
Manager TitleAgeSince
Chief Executive Officer 83 25/10/2009
Director of Finance/CFO - 14/06/2016
Corporate Officer/Principal 55 26/11/2015
Director TitleAgeSince
Chairman 83 25/10/2009
Director/Board Member 72 09/08/2010
Director/Board Member 55 26/10/2009
Change 5-day change 1-year change 3-year change Capi.($)
-0.38%+2.13%-0.09%-49.93% 17Cr
+2.47%+13.21%-41.05%+26.63% 42TCr
+4.08%+12.86%-30.14%+44.89% 24TCr
+6.42%+12.27%-28.57%+12.53% 13TCr
+0.28%+7.28%-30.72%+19.80% 4.9TCr
+3.26%+7.21%-75.12%+169.70% 3.84TCr
+0.92%-7.26%-21.91%+20.91% 2.25TCr
-0.69%+6.85%-24.40%+69.27% 1.99TCr
+1.64%+5.18%-27.88%+8.06% 1.39TCr
+6.56%+12.24%-21.57%+100.81% 1.42TCr
Average +1.56%+7.76%-30.15%+42.27% 10.53TCr
Weighted average by Cap. +1.12%+11.69%-36.17%+36.32%

Financials

2026 *2027 *
Net sales 66Cr 76Cr 62Cr 57Cr 106.27Cr 7.26TCr 107.96Cr 722.63Cr 283.63Cr 3.64TCr 286.33Cr 280.06Cr 12TCr 68Cr 79Cr 64Cr 59Cr 110.22Cr 7.53TCr 111.97Cr 749.47Cr 294.17Cr 3.77TCr 296.96Cr 290.46Cr 12TCr
Net income 2.13Cr 2.46Cr 1.99Cr 1.82Cr 3.43Cr 234.35Cr 3.49Cr 23Cr 9.16Cr 117.46Cr 9.25Cr 9.04Cr 388.33Cr 2.8Cr 3.24Cr 2.61Cr 2.4Cr 4.51Cr 308.07Cr 4.58Cr 31Cr 12Cr 154.41Cr 12Cr 12Cr 510.48Cr
Net Debt 16Cr 19Cr 15Cr 14Cr 26Cr 1.78TCr 27Cr 177.66Cr 70Cr 894.22Cr 70Cr 69Cr 2.96TCr 13Cr 15Cr 12Cr 11Cr 22Cr 1.47TCr 22Cr 146.54Cr 58Cr 737.6Cr 58Cr 57Cr 2.44TCr
Logo Cegedim
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (73.4%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (20.6%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (6%). France accounts for 91.9% of net sales.
Employees
-
Date Price Change
07/26/07 €10.54 -0.38%
06/26/06 €10.58 +0.19%
05/26/05 €10.56 +0.57%
04/26/04 €10.50 +0.19%
03/26/03 €10.48 +1.55%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
10.58EUR
Average target price
15.50EUR
Spread / Average Target
+46.50%

Quarterly revenue - Rate of surprise